Generic Name: interferon beta-1b
Common side effects of Extavia include: uterine hemorrhage, abdominal pain, antibody development, asthenia, chest pain, decreased white blood cell count, fever, flu-like symptoms, headache, hypertonia, increased serum alanine aminotransferase, injection site reaction, insomnia, leukopenia, myalgia, pain, anxiety, arthralgia, constipation, diarrhea, disorder of integument, dizziness, dyspepsia, lymphocytopenia, myasthenia, nausea, peripheral edema, skin rash, urinary urgency, abnormal absolute neutrophil count, chills, and inflammation at injection site. Other side effects include: alopecia, dyspnea, hypertension, leg cramps, lymphadenopathy, palpitations, tachycardia, tissue necrosis at injection site, impotence, nervousness, peripheral vascular disease, urinary frequency, vasodilatation, weight gain, malaise, and diaphoresis.  See below for a comprehensive list of adverse effects.
Applies to interferon beta-1b: subcutaneous powder for solution
In addition to its needed effects, some unwanted effects may be caused by interferon beta-1b (the active ingredient contained in Extavia). In the event that any of these side effects do occur, they may require medical attention.
You should check with your doctor immediately if any of these side effects occur when taking interferon beta-1b:
Some of the side effects that can occur with interferon beta-1b may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:


Applies to interferon beta-1b: subcutaneous powder for injection
Common (1% to 10%): TachycardiaRare (Less than 0.1%): Cardiomyopathy, congestive heart failure, palpitations, arrhythmia, tachycardia, vasodilatation, chest pain, hypertension[Ref]
Very common (10% or more): Skin rashes (25%), increased sweatingCommon (1% to 10%): Contusion, pruritus, erythematous rash, maculopapular rash, night sweatsUncommon (0.1% to 1%): Alopecia, allergic dermatitis, erythema, urticariaRare (0.01% to 0.1%): Skin ulceration/necrosis at the site of injection, Quincke's edema (angioedema), erythema multiforme, Stevens-Johnson syndrome Very rare (less than 0.01%): Calcified subcutaneous nodules, psoriasis, periungual and nail alterationsFrequency not reported: Rash vesicular[Ref]
Uncommon (0.1% to 1%): Hypothyroidism, hyperthyroidism[Ref]
Very common (10% or more): Nausea (27%), diarrhea (17%), constipation (12%), vomiting (10%)Common (1% to 10%): Abdominal painFrequency not reported: Dry mouth, dyspepsia, pancreatitis[Ref]
Influenza-like symptoms (e.g., myalgia, fever, chills, sweating, asthenia, headache, nausea) are the most common adverse reactions.[Ref]
Very common (10% or more): Urinary tract infection (19%), cystitis (11%)Frequency not reported: Metrorrhagia, menorrhagia, urinary incontinence, increase in the frequency of micturition[Ref]
Very common (10% or more): Lymphopenia (14%), leukopenia (11%), neutropenia, thrombocytopenia, anemia Common (1% to 10%): Neutrophil count decreased, hematocrit decreased, blood potassium increased, blood urea nitrogen increasedUncommon (0.1% to 1%): Platelet count decreasedRare (Less than 0.1%): Thrombotic microangiopathy including thrombotic thrombocytopenic purpura/hemolytic uremic syndrome, Frequency not reported: Pancytopenia[Ref]
Very common (10% or more): Alanine aminotransferase increased (26%), aspartate aminotransferase increased (16%)Common (1% to 10%): Gamma-glutamyl-transferase increasedUncommon (0.1% to 1%): Hepatitis (with or without icterus)Rare (Less than 0.1%): Hepatic failure, autoimmune hepatitis Frequency not reported: Elevation of hepatic transaminases (SGPT and SGOT), bilirubinemia, jaundice[Ref]
Rare (Less than 0.1%): Anaphylactic reactionsFrequency not reported: Other allergic reactions[Ref]
Very common (10% or more): Influenza-like symptoms (49%)Frequency not reported: Systemic lupus erythematosus, anaphylactic reaction, anaphylactic shock, hypersensitivity reactions (angioedema, dyspnea, urticaria, rash, pruritic rash)[Ref]
Very common (10% or more): Injection site erythema (62%), injection site pain (15%), injection site pruritus (13%), injection site bruisingCommon (1% to 10%): Injection site edema, injection site warmth, injection site hematoma, injection site rashUncommon (0.1% to 1%): Injection site infections (which could be severe)Rare (Less than 0.1%): Injection site cellulitis (which could be severe) Frequency not reported: Injection site abscess, injection site reaction, injection site inflammation, injection site necrosis, injection site bleeding[Ref]
Frequency not reported: Weight decreased, weight increased[Ref]
Very common (10% or more): Myalgia (19%), back pain (20%), pain in extremity (19%), arthralgia (16%), muscular weakness (12%), muscle spasms (10%)Common (1% to 10%): Muscle spasticity, muscle cramp, neck pain, arthralgia, muscle stiffness, musculoskeletal stiffnessRare (0.01% to 0.1%): Drug induced lupus erythematosus Frequency not reported: Arthritis[Ref]
Very common (10% or more): Headache (67%), dizziness (16%), paresthesia (12%)Common (1% to 10%): HypoesthesiaUncommon (0.1% to 1%): Facial hypoesthesiaFrequency not reported: Neurological symptoms, syncope, hypertonia, seizures, migraine[Ref]
Very common (10% or more): Pyrexia (45%), asthenia (24%), pain (23%), fever (20%), chills (19%)Common (1% to 10%): Fatigue, malaise, hyperthermia, vertigoFrequency not reported: Tachyphylaxis, sudden hearing loss, tinnitus (ototoxic effects resolved 7 to 14 days after discontinuation of the drug)[Ref]
Common (1% to 10%): Depression/suicidal ideation, insomnia, somnolenceUncommon (0.1% to 1%): AnxietyFrequency not reported: Suicide attempt, suicide, psychosis, anxiety, confusion, emotional lability, anhedonia, psychotic thoughts, mood disturbances, hypersexuality, aggressive behavior, panic attacks[Ref]
Rare (Less than 0.1%): Nephrotic syndrome, glomerulosclerosis[Ref]
Very common (10% or more): Oropharyngeal pain (28%), nasopharyngitis (24%), upper respiratory tract infection (21%), cough (16%), sinusitis (14%)Common (1% to 10%): Rhinorrhea, bronchitisRare (0.01% to 0.1%): Dyspnea Frequency not reported: Pulmonary arterial hypertension[Ref]
1. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):
2. "Product Information. Betaseron (interferon beta-1b)." Berlex, Richmond, CA. 
3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
Not all side effects for Extavia may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Abdominal or stomach pain
break in the skin at the injection site, with blue-black discoloration, swelling, or drainage of fluid
flu-like symptoms including chills, fever, generalized feeling of discomfort or illness, increased sweating, and muscle pain
headache or migraine
hives, itching, or swelling at the injection site
irregular or pounding heartbeat
redness, pain, or feeling of heat at the injection site
stuffy nose


Bloody or cloudy urine
breast pain
changes in vision
cold hands and feet
difficult, burning, or painful urination
fast or racing heartbeat
frequent urge to urinate
pain
pelvic pain
swollen glands
troubled breathing
unusual weight gain


Abnormal growth in the breast
benign lumps in the breast
bleeding problems
bloating or swelling
changes in menstrual periods
confusion
convulsions (seizures)
cyst (abnormal growth filled with fluid or semisolid material)
decreased sexual ability in males
dry, puffy skin
feeling cold
hyperactivity
increased muscle tone
increased urge to urinate
loss of memory
mental depression with thoughts of suicide
problems with speaking
red, itching, or swollen eyes
swelling of the front part of the neck
unusual weight loss


Constipation
diarrhea
dizziness
loss of voice
menstrual pain or other changes
unusual tiredness or weakness


Anxiety
drowsiness
hair loss
vomiting

